世界の外分泌膵機能不全治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Exocrine Pancreatic Insufficiency Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5732
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、外分泌膵機能不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（膵酵素補充療法、栄養療法）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・外分泌膵機能不全治療の市場動向
・企業の競争状況、市場シェア
・外分泌膵機能不全治療の種類別市場規模と予測2016-2027（膵酵素補充療法、栄養療法）
・外分泌膵機能不全治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局＆ドラッグストア、その他）
・外分泌膵機能不全治療の北米市場規模2016-2027（アメリカ、カナダ）
・外分泌膵機能不全治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・外分泌膵機能不全治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・外分泌膵機能不全治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・外分泌膵機能不全治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Janssen Pharmaceuticals、Allergan、AzurRx、CHIESI Farmaceutici S.p.A.）
・結論

Exocrine pancreatic insufficiency refers to a medical condition which is characterized by the deficiency of the exocrine pancreatic enzymes.

Market Analysis and Insights: Global Exocrine Pancreatic Insufficiency Therapeutic Market
The global Exocrine Pancreatic Insufficiency Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exocrine Pancreatic Insufficiency Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exocrine Pancreatic Insufficiency Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exocrine Pancreatic Insufficiency Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exocrine Pancreatic Insufficiency Therapeutic market.

Global Exocrine Pancreatic Insufficiency Therapeutic Scope and Market Size
Exocrine Pancreatic Insufficiency Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exocrine Pancreatic Insufficiency Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pancreatic Enzyme Replacement Therapy
Nutritional Therapy

Segment by Application
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Janssen Pharmaceuticals
Allergan
AzurRx
CHIESI Farmaceutici S.p.A.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pancreatic Enzyme Replacement Therapy
1.2.3 Nutritional Therapy
1.3 Market by Application
1.3.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies & Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Perspective (2016-2027)
2.2 Exocrine Pancreatic Insufficiency Therapeutic Growth Trends by Regions
2.2.1 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exocrine Pancreatic Insufficiency Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Exocrine Pancreatic Insufficiency Therapeutic Industry Dynamic
2.3.1 Exocrine Pancreatic Insufficiency Therapeutic Market Trends
2.3.2 Exocrine Pancreatic Insufficiency Therapeutic Market Drivers
2.3.3 Exocrine Pancreatic Insufficiency Therapeutic Market Challenges
2.3.4 Exocrine Pancreatic Insufficiency Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Exocrine Pancreatic Insufficiency Therapeutic Players by Revenue
3.1.1 Global Top Exocrine Pancreatic Insufficiency Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exocrine Pancreatic Insufficiency Therapeutic Revenue
3.4 Global Exocrine Pancreatic Insufficiency Therapeutic Market Concentration Ratio
3.4.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exocrine Pancreatic Insufficiency Therapeutic Revenue in 2020
3.5 Exocrine Pancreatic Insufficiency Therapeutic Key Players Head office and Area Served
3.6 Key Players Exocrine Pancreatic Insufficiency Therapeutic Product Solution and Service
3.7 Date of Enter into Exocrine Pancreatic Insufficiency Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Exocrine Pancreatic Insufficiency Therapeutic Breakdown Data by Type
4.1 Global Exocrine Pancreatic Insufficiency Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Type (2022-2027)

5 Exocrine Pancreatic Insufficiency Therapeutic Breakdown Data by Application
5.1 Global Exocrine Pancreatic Insufficiency Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size (2016-2027)
6.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
6.2.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2027)
6.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
6.3.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2027)
6.4 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
6.4.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size (2016-2027)
7.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
7.2.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2027)
7.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
7.3.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2027)
7.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
7.4.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
8.2.1 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
8.3.1 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region
8.4.1 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size (2016-2027)
9.2 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
9.2.1 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
9.3.1 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
9.4.1 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
10.2.1 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
10.3.1 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
10.4.1 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Exocrine Pancreatic Insufficiency Therapeutic Introduction
11.1.4 AbbVie Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Details
11.2.2 Janssen Pharmaceuticals Business Overview
11.2.3 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Introduction
11.2.4 Janssen Pharmaceuticals Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Exocrine Pancreatic Insufficiency Therapeutic Introduction
11.3.4 Allergan Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 AzurRx
11.4.1 AzurRx Company Details
11.4.2 AzurRx Business Overview
11.4.3 AzurRx Exocrine Pancreatic Insufficiency Therapeutic Introduction
11.4.4 AzurRx Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
11.4.5 AzurRx Recent Development
11.5 CHIESI Farmaceutici S.p.A.
11.5.1 CHIESI Farmaceutici S.p.A. Company Details
11.5.2 CHIESI Farmaceutici S.p.A. Business Overview
11.5.3 CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Introduction
11.5.4 CHIESI Farmaceutici S.p.A. Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
11.5.5 CHIESI Farmaceutici S.p.A. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pancreatic Enzyme Replacement Therapy
Table 3. Key Players of Nutritional Therapy
Table 4. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Regions (2022-2027)
Table 10. Exocrine Pancreatic Insufficiency Therapeutic Market Trends
Table 11. Exocrine Pancreatic Insufficiency Therapeutic Market Drivers
Table 12. Exocrine Pancreatic Insufficiency Therapeutic Market Challenges
Table 13. Exocrine Pancreatic Insufficiency Therapeutic Market Restraints
Table 14. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Exocrine Pancreatic Insufficiency Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exocrine Pancreatic Insufficiency Therapeutic as of 2020)
Table 17. Ranking of Global Top Exocrine Pancreatic Insufficiency Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Exocrine Pancreatic Insufficiency Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exocrine Pancreatic Insufficiency Therapeutic Product Solution and Service
Table 21. Date of Enter into Exocrine Pancreatic Insufficiency Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Exocrine Pancreatic Insufficiency Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Exocrine Pancreatic Insufficiency Therapeutic Product
Table 64. AbbVie Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Janssen Pharmaceuticals Company Details
Table 67. Janssen Pharmaceuticals Business Overview
Table 68. Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Product
Table 69. Janssen Pharmaceuticals Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Janssen Pharmaceuticals Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Exocrine Pancreatic Insufficiency Therapeutic Product
Table 74. Allergan Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. AzurRx Company Details
Table 77. AzurRx Business Overview
Table 78. AzurRx Exocrine Pancreatic Insufficiency Therapeutic Product
Table 79. AzurRx Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021) & (US$ Million)
Table 80. AzurRx Recent Development
Table 81. CHIESI Farmaceutici S.p.A. Company Details
Table 82. CHIESI Farmaceutici S.p.A. Business Overview
Table 83. CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Product
Table 84. CHIESI Farmaceutici S.p.A. Revenue in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021) & (US$ Million)
Table 85. CHIESI Farmaceutici S.p.A. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Pancreatic Enzyme Replacement Therapy Features
Figure 3. Nutritional Therapy Features
Figure 4. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies & Drug Stores Case Studies
Figure 7. Others Case Studies
Figure 8. Exocrine Pancreatic Insufficiency Therapeutic Report Years Considered
Figure 9. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Players in 2020
Figure 14. Global Top Exocrine Pancreatic Insufficiency Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exocrine Pancreatic Insufficiency Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Exocrine Pancreatic Insufficiency Therapeutic Revenue in 2020
Figure 16. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Exocrine Pancreatic Insufficiency Therapeutic Market Share by Region (2016-2027)
Figure 38. China Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Exocrine Pancreatic Insufficiency Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
Figure 58. Janssen Pharmaceuticals Revenue Growth Rate in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
Figure 59. Allergan Revenue Growth Rate in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
Figure 60. AzurRx Revenue Growth Rate in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
Figure 61. CHIESI Farmaceutici S.p.A. Revenue Growth Rate in Exocrine Pancreatic Insufficiency Therapeutic Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4649 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、膵臓がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膵嚢胞診断市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cyst Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4650 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、膵嚢胞診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRIスキャン診断、CTスキャン診断、超音波スキャン診断）、用途別市場規模（病院、診断センター、学術研究機関、専門クリニック）、主要地域別市場...

世界の膵液瘻治療市場規模・現状・予測（2021年-2027年）

Global Pancreatic Fistula Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4651 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、膵液瘻治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術用デバイス）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の膵石タンパク質検査市場規模・現状・予測（2021年-2027年）

Global Pancreatic Stone Protein Testing Market Size, Status and Forecast 2021-2027
QFJ1-4652 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、膵石タンパク質検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、蛍光イムノアッセイ）、用途別市場規模（病院、専門クリニック、診断センター、病理学研究所、その他）、主要地域別市場規模（北米...

世界の膵臓がん診断装置市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Diagnostic Devices Market Size, Status and Forecast 2021-2027
QFJ1-5288 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、膵臓がん診断装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イメージング、腫瘍バイオマーカー、生検、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5837 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、リンパ芽球性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞移植、標的療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のマゴットセラピー市場規模・現状・予測（2021年-2027年）

Global Maggot Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4454 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、マゴットセラピーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬品、薬用包帯、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のアフェレシス療法市場規模・現状・予測（2021年-2027年）

Global Therapeutic Apheresis Market Size, Status and Forecast 2021-2027
QFJ1-4950 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、アフェレシス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療用血漿交換、赤血球交換）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の寄生虫病治療市場規模・現状・予測（2021年-2027年）

Global Parasitic Diseases Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5930 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、寄生虫病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペプチド薬、防虫剤、殺ダニ剤、その他）、用途別市場規模（商業用、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
世界のゴーシェ病＆ポンペ病酵素補充療法市場規模・現状・予測（2021年-2027年） Enzyme replacement therapy (ERT) involves intravenous (IV) infusions to correct the underlying enzyme deficiency that causes symptoms of Gaucher disease Market Analysis and Insights: Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market The global Gaucher and Pompe Diseases Enzyme Repl…
世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
世界の膵嚢胞診断市場規模・現状・予測（2021年-2027年） The growth of sac-like pocket filled with fluid on the pancreas is called pancreatic cyst. Majority of pancreatic cyst is non-cancerous while in a few cases it may develop benign cancer. Market Analysis and Insights: Global Pancreatic Cyst Diagnostics Market The global Pancreatic Cyst Diagnostics ma…
世界の膵液瘻治療市場規模・現状・予測（2021年-2027年） A pancreatic fistula is an abnormal communication between the pancreas and other organs due to leakage of pancreatic secretions from damaged pancreatic ducts. Market Analysis and Insights: Global Pancreatic Fistula Treatment Market The global Pancreatic Fistula Treatment market size is projected to …